Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible.

Authors
  • Fogarty, Gerald B1
  • Hong, Angela
  • Jacobsen, Kari Dolven
  • Reisse, Claudius H
  • Shivalingam, Brindha
  • Burmeister, Bryan
  • Haydu, Lauren E
  • Paton, Elizabeth
  • Thompson, John F
Type
Published Article
Journal
BMC Research Notes
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Jun 30, 2014
Volume
7
Pages
412–412
Identifiers
DOI: 10.1186/1756-0500-7-412
PMID: 24981506
Source
Medline
License
Unknown

Abstract

Despite only 54 patients and not the full 60 patient target being accrued in two years the Trial Management Committee and Data Safely Monitoring Committee approved the continuation of the pilot study to the main trial. On the basis of this successful pilot study, funding was achieved for the full study. 143 patients of a target of 200 have been randomised by June 2014.

Report this publication

Statistics

Seen <100 times